Report

Primary Care Perspectives on GLP-1 Prescriptions

Partner Insights from

Thank you for your interest. You can now access the asset below.

{download_button}

Welcome back.

You have registered as {email}. .

{download_button}

Download now

As GLP-1 demand skyrockets, employers are being flooded with third-party telehealth prescribing options for the popular medications. Are third-party prescribers a safe and effective solution for employees? To learn more, Omada Health surveyed over 2,000 primary care physicians in partnership with Sermo. Read the full survey report to help inform your benefit strategy.

The survey report includes:

Responses from over 2,000 primary care physicians (PCPs)
GLP-1 prescribing trends and what drives PCP prescribing decisions
Safety concerns associated with third-party telehealth providers prescribing GLP-1s
Complexities of compounded GLP-1s and supply strategy

Download Survey Report: Primary Care Perspectives on GLP-1 Prescriptions to learn more.

_{By submitting your information, you are signing up to receive offers, promotions and other commercial messages from Omada Health. You may unsubscribe from receiving these communications at any time. For more information on how we use your information, take a look at Omada's privacy policy and state privacy notices.*}